Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ascend Vitality vs RegenCen

Ascend Vitality
Graded #307

Higher grade

vs+1.1000000000000014
RegenCen
Graded #334

Lower grade

The verdict

Ascend Vitality takes it — 60.9/100 to 59.8/100, but only just.

Ascend Vitality grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ascend Vitality is a cash-pay GLP-1 telehealth provider offering compounded semaglutide (starting at $199/mo) and compounded tirzepatide (starting at $299/mo) as both weekly injectables and needle-free… RegenCen is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAscend Vitality +5
50
45
Dose & formulationAscend Vitality +35
75
40
Clinical oversightRegenCen +6
74
80
Labs & monitoringRegenCen +33
52
85
FulfillmentAscend Vitality +3
65
62
Contract termsRegenCen +18
37
55
Ascend Vitality · left barRegenCen · right bar

The numbers

MetricAscend VitalityRegenCen
WeighScore60.9/10059.8/100
GradeCC
Scorecard rank#307#334
Semaglutide$199/mo (compounded)Not disclosed
Tirzepatide$299/mo (compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Ascend Vitality

Graded #307 · C

Strengths

  • Both injectable and needle-free oral tablet forms of semaglutide and tirzepatide
  • LegitScript certified
  • Transparent cash-pay pricing with cancel-anytime subscription
  • Legal entity and address publicly disclosed (Ascend Vitality LLC, Sheridan, WY)

Where it loses points

  • All medications are compounded — FDA does not review compounded drugs for safety/effectiveness
  • No named compounding pharmacy partner disclosed
  • No public state-by-state availability list (homepage cites exclusions: LA, MS, KS, NM, WV)
  • Per-dose/titration pricing not published; only 'starting at' prices shown
RegenCen

Graded #334 · C

Strengths

  • Virtual consultations by video or phone for MI and FL patients
  • MD-led oversight (Dr. Gustav Lo) plus PA co-founder
  • Menopause Society Certified Practitioners on staff
  • GLP-1 paired with coaching and metabolic care
  • Bundles weight loss with bioidentical hormone therapy

Where it loses points

  • Telehealth limited to Michigan and Florida
  • No published GLP-1 medication pricing
  • No named pharmacy or medication sourcing details
  • Menopause/women's focus rather than weight-loss-only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard